The pediatric drugs market in India grew at a staggering CAGR of ~% during the period FY'2011-FY'2016 exhibiting the annual revenue of INR ~ billion in FY'2011 which inclined to INR ~ billion in FY'2016.

1. The Market for Pediatric Drugs In India Is Expected to cross
INR 960 Billion in the Future: Ken Research

2. India pediatric drugs and vaccine market has witnessed
tremendous growth in the last five years largely due to high
number of annual births recorded at around 25 million,
launch of generic formulations of several pediatric drugs
including flavored TB drugs, inclusion of several vaccines in
the national immunization schedule of the country and
inclining coverage of children vaccination under national
immunization schedule.

3. In the last few years, medium to large Indian pharmaceutical
companies have aggressively invested in international
acquisition of companies to strengthen their foothold in
developed and emerging markets globally.
India’s healthcare spending is one of the lowest in the world
with the country spending only 1.2% of its GDP on health
care as compared to 8.3% by the US and global mean of
5.4%, as of FY’2016. It also has the highest infant mortality
rate and maternal mortality rate in the world. This has
propelled the pharmaceutical industry to address the existing
unmet challenges. The industry has come out with drug
formulations for infants against some life threatening
diseases such as tuberculosis and pneumonia which has
helped to curb down the infant mortality rate in the country.

4. The market for pediatric drugs and vaccines in India is almost
entirely driven by companies manufacturing generic drugs.
Almost all pharmaceutical companies operating in the country
have expertise in developing generic drugs formulations of
branded drugs developed by international companies so as to
cater with underprivileged populations at a much cheaper price.
India has a huge disease burden and a large part of drugs sold in
the country is meant for the treatment of several infectious and
non-infectious diseases prevalent in the pediatric population.
Pediatric drug are commonly used for diarrheal diseases such as
cholera and viral gastroenteritis. Respiratory diseases including
pneumonia and tuberculosis are other commonly treatable
conditions for which drugs find extensive usage in the country.

5. Anti-infectives were the most frequently prescribed drug class
by pediatricians, with over 80% of the prescriptions had some
form of prescribed antibiotics. This is due to the wide scale
prevalence of children being affected by respiratory diseases or
some sort of microbial infections at regular basis.
India has emerged as leading vaccine producer in the world, in
terms of doses of vaccines produced, and has about 12 major
vaccine manufacturing facilities across the country. Vaccines
manufactured in these facilities are offered in both national and
international market (over 150 countries). With over 25 million
births every year, the domestic market for vaccines in India is
huge. The country has been self sufficient in meeting the
domestic needs, with private sector responsible for providing a
large part of the supply needs.

6. Key Factors Considered in the Report
Pediatric Drug Development
Trends Pediatric Vaccine Market
Number Of Pediatrician Statistics
Pediatric Tuberculosis Drug Market
Drug Information, Dosage, Side Effects
Vaccines Market Growth India
Drug Pipeline Pediatric Drug
Vaccine Clinical Trials India
Pediatric Drug Market Industry Size
New Drug Launches India Pharma Sector
Pediatric Vaccine Serum Institute Of India

7. For more information on the market research report please
refer to the below link:
https://www.kenresearch.com/healthcare/pharmaceuticals/in
dia-pediatric-drug-vaccine-market/81319-91.html
Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
Ankur@kenresearch.com
+91-9015378249